Formycon Raises Fresh Capital To Drive Biosimilar Development

Funding For COVID-19 Also Received

Euro currency
The €25.75m investment will go towards biosimilar investment • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products